These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33809082)

  • 41. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
    Shimbo E; Nukuzuma S; Tagawa YI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
    Trampe AK; Hemmelmann C; Stroet A; Haghikia A; Hellwig K; Wiendl H; Goelz S; Ziegler A; Gold R; Chan A
    Neurology; 2012 May; 78(22):1736-42. PubMed ID: 22592369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of droplet digital PCR for the quantitative detection of polyomavirus JC in clinical samples.
    Giovannelli I; Ciccone N; Vaggelli G; Malva ND; Torricelli F; Rossolini GM; Giannecchini S
    J Clin Virol; 2016 Sep; 82():70-75. PubMed ID: 27454232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
    Iannetta M; Zingaropoli MA; Bellizzi A; Morreale M; Pontecorvo S; D'Abramo A; Oliva A; Anzivino E; Lo Menzo S; D'Agostino C; Mastroianni CM; Millefiorini E; Pietropaolo V; Francia A; Vullo V; Ciardi MR
    PLoS One; 2016; 11(8):e0160277. PubMed ID: 27486658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
    Basnyat P; Hagman S; Kolasa M; Koivisto K; Verkkoniemi-Ahola A; Airas L; Elovaara I
    Mult Scler Relat Disord; 2015 Jul; 4(4):334-8. PubMed ID: 26195052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of Spanish Multiple Sclerosis patients treated with natalizumab.
    Dominguez-Mozo MI; Garcia-Montojo M; De Las Heras V; Garcia-Martinez A; Arias-Leal AM; Casanova I; Arroyo R; Alvarez-Lafuente R
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1277-86. PubMed ID: 23979860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type O blood group associates with higher anti-JC polyomavirus antibody levels.
    Frenken P; Hartung HP; Olsson T; Adams O; Warnke C
    Brain Behav; 2021 Aug; 11(8):e2298. PubMed ID: 34291599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High cumulative JC virus seroconversion rate during long-term use of natalizumab.
    Vennegoor A; van Rossum JA; Leurs C; Wattjes MP; Rispens T; Murk JL; Uitdehaag BM; Killestein J
    Eur J Neurol; 2016 Jun; 23(6):1079-85. PubMed ID: 27018481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients.
    Yao K; Gagnon S; Akhyani N; Williams E; Fotheringham J; Frohman E; Stuve O; Monson N; Racke MK; Jacobson S
    PLoS One; 2008 Apr; 3(4):e2028. PubMed ID: 18446218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.
    Classen G; Classen C; Bernasconi C; Brandt C; Gold R; Chan A; Hoepner R
    J Neurovirol; 2019 Feb; 25(1):133-136. PubMed ID: 30414049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early reduction of the splicing factor2/alternative splicing factor: a cellular inhibitor of the JC polyomavirus in natalizumab-treated MS patients long before developing progressive multifocal leukoencephalopathy.
    Piu C; Ibba G; Bertoli D; Capra R; Uleri E; Serra C; Imberti L; Dolei A
    J Neurovirol; 2020 Feb; 26(1):133-137. PubMed ID: 31468472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natalizumab therapy is associated with changes in serum JC virus antibody indices over time.
    Peters J; Williamson E
    J Neurol; 2017 Dec; 264(12):2409-2412. PubMed ID: 29034436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.
    Pietropaolo V; Bellizzi A; Anzivino E; Iannetta M; Zingaropoli MA; Rodio DM; Morreale M; Pontecorvo S; Francia A; Vullo V; Palamara AT; Ciardi MR
    J Neurovirol; 2015 Dec; 21(6):653-65. PubMed ID: 25930159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
    Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Takegami T
    Microbiol Immunol; 2017 Jun; 61(6):232-238. PubMed ID: 28463406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutations in the John Cunningham virus VP1 gene could predispose to the development of progressive multifocal leukoencephalopathy in multiple sclerosis patients undergoing treatment with natalizumab.
    Flores J; Anguiano O; Rivas-Alonso V; González-Conchillos H; Pérez-Saldivar M; Sotelo J; Magaña-Maldonado R; Quiñones S; Corona T; Olivares H; Hernández-González O; Martínez-Palomo A; Treviño I; Ordoñez G
    Mult Scler Relat Disord; 2021 Nov; 56():103266. PubMed ID: 34555758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
    Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natalizumab: Perspectives from the Bench to Bedside.
    Shirani A; Stüve O
    Cold Spring Harb Perspect Med; 2018 Dec; 8(12):. PubMed ID: 29500304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reemergence of PML in natalizumab-treated patients--new cases, same concerns.
    Major EO
    N Engl J Med; 2009 Sep; 361(11):1041-3. PubMed ID: 19741226
    [No Abstract]   [Full Text] [Related]  

  • 59. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
    JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
    Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
    J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.